GlassScriptPhysician profile
Shahid S Malik
NPI 1306866058
$3,004.34
in general payments reported to CMS, 2019-2025
31 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $256 · 2021: $243 · 2022: $705 · 2023: $781 · 2024: $297 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $454.73 | 2019-2024 | Mitraclip |
| Boston Scientific Corporation | $434.14 | 2019-2024 | Rotablator Rotational Atherectomy System Console Kit, Comet, Watchman Access System |
| Kestra Medical Technology Services, INC. | $424.03 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $329.38 | 2019-2024 | Lifevest |
| Abiomed | $255.55 | 2019-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.11 | 2019-2023 | Jardiance |
| Pfizer INC. | $110.51 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $91.88 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $89.83 | 2021-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $85.17 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $84.86 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $48.41 | 2019-2021 | |
| Esperion Therapeutics, INC. | $38.91 | 2020-2021 | |
| Astellas Pharma US INC | $32.30 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $31.25 | 2020-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $29.91 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $26.80 | 2023 | Opsumit, Uptravi |
| Cvrx, INC. | $24.92 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $24.35 | 2019 | |
| Infobionic, INC | $24.29 | 2020 | |
| Philips North America LLC | $23.13 | 2024 | (Ck7) Extended Holter |
| Sanofi-Aventis U.S. LLC | $20.11 | 2019 | |
| Amgen INC. | $17.97 | 2025 | Repatha |
| Shockwave Medical, INC | $16.32 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Glaxosmithkline, LLC. | $15.48 | 2025 | Shingrix, Arexvy |
| Ge Healthcare | $14.97 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $14.38 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $13.76 | 2023 | Optimizer |
| Biotronik INC. | $13.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.62 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahid Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.